Showing 1 - 20 results of 23 for search 'T. Shanafelt', query time: 0.04s
Refine Results
-
1
Stability trophic cascades in food chains by David W. Shanafelt, Michel Loreau
Published 2018-01-01
Article -
2
-
3
-
4
-
5
Distress and well-being in dentists: performance of a screening tool for assessment by Subha Giri, Colin P. West, Tait Shanafelt, Daniel Satele, Liselotte N. Dyrbye
Published 2024-01-01
Article -
6
-
7
Change in the implementation of healthy nutrition and physical activity best practices in Minnesota early care settings: A longitudinal cohort study (2010–2016) by Marilyn S. Nanney, Cynthia Davey, Samantha Mosbrucker, Amy Shanafelt, Natasha Frost, Allison Anfinson, Marguerite Zauner, Katie Loth
Published 2018-06-01
Article -
8
-
9
-
10
-
11
-
12
-
13
Project BreakFAST: Rationale, design, and recruitment and enrollment methods of a randomized controlled trial to evaluate an intervention to improve school breakfast program partic... by Marilyn S. Nanney, Amy Shanafelt, Qi Wang, Robert Leduc, Ellen Dodds, Mary Hearst, Martha Y. Kubik, Katherine Grannon, Lisa Harnack
Published 2016-08-01
Article -
14
-
15
Describing the emotional exhaustion, depersonalization, and low personal accomplishment symptoms associated with Maslach Burnout Inventory subscale scores in US physicians: an item... by Keri J. S. Brady, Pengsheng Ni, R. Christopher Sheldrick, Mickey T. Trockel, Tait D. Shanafelt, Susannah G. Rowe, Jeffrey I. Schneider, Lewis E. Kazis
Published 2020-06-01
Article -
16
P627: LONG-TERM OUTCOMES WITH CONTINUOUS IBRUTINIB IN PATIENTS WITH CHRONIC LYMPHOCYTIC LEUKEMIA: ANALYSIS OF TIME TO PROGRESSION by Thomas Kipps, Carolyn Owen, Ian W. Flinn, Paul M. Barr, Alessandra Tedeschi, Richard Greil, Edith Szafer-Glusman, Hsin-Hui Huang, Lynne Neumayr, Chris Abbazio, Tait Shanafelt
Published 2023-08-01
Article -
17
PB1878: CROSS-TRIAL ANALYSIS OF FIXED-DURATION IBRUTINIB (I) PLUS VENETOCLAX (V) VS FLUDARABINE (F), CYCLOPHOSPHAMIDE (C), AND RITUXIMAB (R) AS FIRST-LINE TREATMENT FOR CHRONIC LYM... by J. C. Barrientos, P. M. Barr, A. R. Mato, C. S. Tam, P. Ghia, C. Moreno, N. E. Kay, T. Siddiqi, E. Szafer-Glusman, C. Zhou, L. Neumayr, G. Krigsfeld, W. G. Wierda, T. Shanafelt
Published 2022-06-01
Article -
18
The risk of coronavirus disease 2019 (COVID-19) among individuals with monoclonal B cell lymphocytosis by Sameer A. Parikh, Sara J. Achenbach, Kari G. Rabe, Aaron D. Norman, Nicholas J. Boddicker, Janet E. Olson, Timothy G. Call, James R. Cerhan, Celine M. Vachon, Neil E. Kay, Esteban Braggio, Curtis A. Hanson, Susan L. Slager, Tait D. Shanafelt
Published 2022-11-01
Article -
19
Cause of death in patients with newly diagnosed chronic lymphocytic leukemia (CLL) stratified by the CLL-International Prognostic Index by Yucai Wang, Sara J. Achenbach, Kari G. Rabe, Tait D. Shanafelt, Timothy G. Call, Wei Ding, Saad S. Kenderian, Eli Muchtar, Jose F. Leis, Amber B. Koehler, Susan M. Schwager, James R. Cerhan, Susan L. Slager, Neil E. Kay, Sameer A. Parikh
Published 2021-08-01
Article -
20
Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia. by Slager, S, Skibola, C, Bernardo, D, Conde, L, Broderick, P, McDonnell, S, Goldin, L, Croft, N, Holroyd, A, Harris, S, Riby, J, Serie, D, Kay, N, Call, T, Bracci, P, Halperin, E, Lanasa, M, Cunningham, J, Leis, J, Morrison, V, Spector, L, Vachon, C, Shanafelt, T, Strom, S, Camp, N
Published 2012Journal article